home / stock / enlv / enlv quote
Last: | $ |
---|---|
Change Percent: | 6.59% |
Open: | $8.35 |
Close: | $8.74 |
High: | $8.74 |
Low: | $8.231 |
Volume: | 5,431 |
Last Trade Date Time: | 02/12/2020 04:40:51 pm |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$ | $8.35 | $8.74 | $8.74 | $8.231 | 5,431 | 02-12-2020 |
$ | $8.60 | $8.20 | $8.60 | $8.00 | 8,670 | 02-11-2020 |
$ | $8.08 | $8.26 | $8.54 | $8.08 | 24,912 | 02-10-2020 |
$ | $7.6101 | $7.75 | $7.75 | $7.6101 | 4,351 | 02-07-2020 |
$ | $7.29 | $7.7108 | $7.79 | $7.29 | 9,029 | 02-06-2020 |
$ | $7.46 | $6.88 | $7.8724 | $6.88 | 28,396 | 02-05-2020 |
$ | $7.90 | $7.57 | $7.96 | $7.50 | 19,929 | 02-04-2020 |
$ | $7.65 | $7.70 | $7.7385 | $7.65 | 3,756 | 02-03-2020 |
$ | $8.11 | $7.99 | $8.15 | $7.54 | 3,719 | 01-31-2020 |
$ | $8.10 | $8.16 | $8.43 | $8.10 | 6,956 | 01-30-2020 |
$ | $8.63 | $8.30 | $8.6396 | $8.30 | 5,781 | 01-29-2020 |
$ | $8.57 | $8.98 | $8.98 | $8.3114 | 2,070 | 01-28-2020 |
$ | $8.38 | $8.51 | $8.5701 | $8.22 | 15,643 | 01-27-2020 |
$ | $9.70 | $9.0952 | $9.70 | $9.05 | 4,211 | 01-24-2020 |
$ | $9.88 | $9.91 | $9.91 | $9.50 | 3,375 | 01-23-2020 |
$ | $9.35 | $9.81 | $10.00 | $9.35 | 19,497 | 01-22-2020 |
$ | $9.05 | $9.056 | $9.15 | $8.92 | 18,140 | 01-21-2020 |
$ | $8.54 | $8.928 | $8.9552 | $8.54 | 29,088 | 01-20-2020 |
$ | $8.54 | $8.928 | $8.9552 | $8.54 | 29,088 | 01-17-2020 |
$ | $8.92 | $8.54 | $8.92 | $8.54 | 27,969 | 01-16-2020 |
News, Short Squeeze, Breakout and More Instantly...
Enlivex Therapeutics Ltd. Company Name:
ENLV Stock Symbol:
NYSE Market:
Nes-Ziona, Israel, April 22, 2024 (GLOBE NEWSWIRE) -- Enlivex Therapeutics Ltd. (Nasdaq: ENLV, the “Company”), a clinical-stage macrophage reprogramming immunotherapy company, today announced that the first two patients have been dosed in the Company’s multi-country, random...
Nes-Ziona, Israel, April 16, 2024 (GLOBE NEWSWIRE) -- Enlivex Therapeutics Ltd. (Nasdaq: ENLV, the “Company”), a clinical-stage macrophage reprogramming immunotherapy company, today announced that the Danish Medicines Agency (DKMA) authorized the expansion into Denmark of the Comp...
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgr...